Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
The construction of selectively activated prodrugs serves as a crucial strategy for reducing the adverse effects associated with disease treatment. Cascade self-assembled visual prodrugs have been applied to the construction of selective activated prodrugs with low background interference and fluorescence. In this work, we rationally designed an anticancer theranostic prodrug (CM-PPT) consisting of an anticancer drug podophyllotoxin, a fluorescent dye precursor, and an HO trigger boronate ester group, which could be activated by HO oxidation, thereby releasing active anticancer molecules and forming fluorescent fragments concurrently. experiments revealed that the prodrug has potent anticancer efficacy, and the drug release rate could be visualized by the fluorescence intensity. In addition, intraperitoneal administration of the prodrug to mice demonstrated outstanding antitumor activities. Thus, this design of HO-responsive prodrug may provide a promising strategy for selective imaging of HO status, real-time tracking of drug release, and personalized tumor treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d4tb02182g | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!